Explore the Agenda

8:00 am Morning Registration & Light Breakfast

8:50 am Chair’s Opening Remarks

Chief Executive Officer, Kula Bio Inc.

Bridging the Lab-to-Field Gap Through Integrated Research & Field Validation to Create Reliable & Trusted Field Trials

9:00 am Separating Signal from Noise in Biological Product Trials for Reliable Product Outcomes

Vice President, R&D, NewLeaf Symbiotics
  • Disentangling biological signal from environmental and management variability in on-farm trials
  • Applying statistical and experimental controls tailored specifically to living products
  • Building confidence in outcomes through replication strategies and cross-site validation

9:30 am Designing Trials that Drive Adoption & Commercial Value by Earning Grower Trust Through Field Evidence

BSIN & Technical Development Manager, UPL
  • Designing field trials that answer grower and buyer questions tied to risk, return on investment, and repeat purchase decisions
  • Demonstrating consistency and reliability at scale and forming conditions that reflect real commercial farming operations
  • Translating field data into credible value stories that support sales, claims, and longterm market adoption

10:00 am Morning Break & Speed Networking

Join our speed networking session tailored for agbiotech professionals, distributors, investors, growers, service providers and more, to connect with fellow industry peers and facilitate rapid, yet meaningful exchanges of insights and expertise. Elevate your conference experience during this session designed to form impactful connections within the space.

Translating Novel Microbe Discovery & Innovating High-Impact Biostimulants & Biocontrol Solutions for Improved Efficacy of New Products

11:00 am Designing Engineered Microbial Strains to Be Effective, Stable & Easy-to Use Products

Chief Executive Officer & Founder, Robigo
  • Designing the product concept with efficacy, downstream scale-up, application method, and regulatory requirements in mind
  • Decoupling strain selection from biocontrol activity to enable more stable and competitive microbial products

11:30 am Decoding Mechanisms of Action in Biological Products to Drive Reliable Field Efficacy

Principal Scientist & Product Manager, Indigo Ag
  • Characterizing microbial and biochemical mechanisms of action using molecular, biochemical, and physiological assays to link function with agronomic outcomes
  • Validating mechanisms of action through controlled experimental systems that distinguish biological activity from environmental and background effects
  • Translating mechanistic insight into improved product design, formulation strategy, and performance consistency under variable use conditions

12:00 pm Designing Effective Biostimulants to Improve Performance Consistency, Grower Confidence & Yield Outcomes

Technical Development Lead, BASF
  • Developing biostimulant products that deliver consistent, measurable performance under variable field and environmental conditions
  • Improving performance consistency through better formulation, validation, and field relevant testing to build grower confidence and support healthier yields
  • Aligning scientific evidence, product positioning, and expectation management to drive correct use and sustained biostimulant adoption

12:30 pm Session Reserved for Reshape Biotech

1:00 pm Lunch Break & Networking

Optimizing Fermentation & Formulation to Deliver Consistent, Scalable Bioproduct Performance

2:00 pm Advancing Formulation Strategies to Extend Shelf Life & Field Efficacy

Assistant Director, R&D, Kula Bio Inc.
  • Addressing formulation challenges for fragile biologicals, including gram-negative bacteria and complex multi-component systems
  • Evaluating the role of adjuvants, pH control, tank additives, and carriers in survivability on leaf and soil surfaces
  • Designing formulation workflows with early chemist involvement to ensure compatibility with commercial farming practices

2:30 pm Roundtable: Integrating Fermentation, Formulation, & Novel Inputs for Next-Generation Biologicals

Brand Portfolio Manager, Wilbur-Ellis Holdings Inc.
  • Exploring fermentation and formulation approaches for peptides, metabolites, and other emerging biological technologies
  • Developing synergistic products combining microbes with nutrients, stimulants, or novel biological actives
  • Innovating out-of-the-box production and formulation models, including miniaturized manufacturing, energy-efficient systems, and circular-economy approaches 

3:00 pm Session Reserved for PhycoTerra

3:30 pm Afternoon Break & Poster Session

Contribute to the conversation and share your cutting-edge research with the agbiological community. Register your place to submit an abstract for review and showcase your work. Please visit the website for the T&Cs of presenting a poster

De-Risking AgBioTech Innovation Through Smarter Regulatory Strategy to Streamline Approvals & Create Improved, Compliant Products

4:30 pm Roundtable Discussion: Perspectives on Regulatory Readiness for Agricultural Microbiomes & Biostimulants

  •  Clarifying how regulator roles and interagency coordination (USDA and/or EPA) shapes pathways to market for microbial and biostimulant products
  • Outlining regulatory expectations genetically modified microbes, data gaps, and scientific priorities needed to support risk-based, science-driven oversight
  • Updating stakeholders on biostimulant harmonization efforts, state-level considerations, and opportunities for early engagement with regulators

5:00 pm Improving on Regulatory Success & Reducing Cost with Aligned Data Sets that Allow for Expansion into Global Markets

Lead Regulatory Affairs, North America & Global Biologics, Plant Health Care
  • Discuss how harmonized global data packages provide the opportunity to streamline regulatory submissions and reduce duplication of costly regional studies
  • Identify that the first critical step to aligning across jurisdictions is to develop standardized datasets based on a comprehensive overview of fermentation processes, QM/QA/QC parameters, and product specifications
  • Participate in proactive dialogue with regulatory authorities to fully describe product composition, innovations in product fermentation and formulation to develop crossborder datasets that support scalable regulatory and commercialization strategies for new territories

5:30 pm Chair’s Closing Remarks

Chief Executive Officer, Kula Bio Inc.

5:40 pm End of Conference Day One